Johnson & Johnson (JNJ) Shares Sold by Exchange Capital Management Inc.

Exchange Capital Management Inc. lowered its stake in Johnson & Johnson (NYSE:JNJ) by 37.9% during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 42,066 shares of the company’s stock after selling 25,622 shares during the quarter. Johnson & Johnson comprises approximately 1.9% of Exchange Capital Management Inc.’s holdings, making the stock its 14th largest holding. Exchange Capital Management Inc.’s holdings in Johnson & Johnson were worth $5,565,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds also recently made changes to their positions in the company. OLD Point Trust & Financial Services N A lifted its stake in Johnson & Johnson by 2.2% in the 2nd quarter. OLD Point Trust & Financial Services N A now owns 61,326 shares of the company’s stock worth $8,113,000 after purchasing an additional 1,321 shares in the last quarter. Lynch & Associates IN lifted its stake in Johnson & Johnson by 0.9% in the 2nd quarter. Lynch & Associates IN now owns 93,710 shares of the company’s stock worth $12,397,000 after purchasing an additional 841 shares in the last quarter. Oakbrook Investments LLC lifted its stake in Johnson & Johnson by 7.4% in the 2nd quarter. Oakbrook Investments LLC now owns 136,124 shares of the company’s stock worth $18,008,000 after purchasing an additional 9,375 shares in the last quarter. Trexquant Investment LP purchased a new stake in Johnson & Johnson in the 1st quarter worth $1,731,000. Finally, Janney Montgomery Scott LLC lifted its stake in Johnson & Johnson by 0.5% in the 2nd quarter. Janney Montgomery Scott LLC now owns 771,868 shares of the company’s stock worth $102,110,000 after purchasing an additional 3,533 shares in the last quarter. Institutional investors and hedge funds own 66.06% of the company’s stock.

A number of analysts have recently weighed in on the stock. Vetr upgraded shares of Johnson & Johnson from a “sell” rating to a “hold” rating and set a $137.71 target price on the stock in a report on Tuesday, October 24th. Citigroup Inc. boosted their target price on shares of Johnson & Johnson from $140.00 to $149.00 and gave the stock a “buy” rating in a report on Monday, October 23rd. J P Morgan Chase & Co boosted their target price on shares of Johnson & Johnson from $140.00 to $148.00 and gave the stock an “overweight” rating in a report on Wednesday, August 16th. Leerink Swann restated an “outperform” rating and issued a $165.00 target price (up from $150.00) on shares of Johnson & Johnson in a report on Wednesday, October 18th. Finally, BMO Capital Markets restated a “positive” rating and issued a $152.00 target price (up from $145.00) on shares of Johnson & Johnson in a report on Wednesday, October 18th. Four analysts have rated the stock with a sell rating, eight have given a hold rating and eleven have issued a buy rating to the company’s stock. Johnson & Johnson currently has a consensus rating of “Hold” and a consensus target price of $143.70.

WARNING: “Johnson & Johnson (JNJ) Shares Sold by Exchange Capital Management Inc.” was published by Community Financial News and is owned by of Community Financial News. If you are accessing this news story on another website, it was copied illegally and republished in violation of U.S. and international trademark and copyright law. The correct version of this news story can be accessed at https://www.com-unik.info/2017/11/03/johnson-johnson-jnj-shares-sold-by-exchange-capital-management-inc.html.

Johnson & Johnson (NYSE:JNJ) last announced its quarterly earnings results on Tuesday, October 17th. The company reported $1.90 earnings per share for the quarter, beating analysts’ consensus estimates of $1.80 by $0.10. Johnson & Johnson had a net margin of 21.28% and a return on equity of 27.68%. The business had revenue of $19.65 billion during the quarter, compared to analysts’ expectations of $19.29 billion. During the same period last year, the business earned $1.68 earnings per share. The business’s revenue for the quarter was up 10.3% on a year-over-year basis.

The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 12th. Shareholders of record on Tuesday, November 28th will be given a dividend of $0.84 per share. This represents a $3.36 dividend on an annualized basis and a dividend yield of 2.40%. The ex-dividend date of this dividend is Monday, November 27th. Johnson & Johnson’s dividend payout ratio is presently 58.33%.

About Johnson & Johnson

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being.

Institutional Ownership by Quarter for Johnson & Johnson (NYSE:JNJ)

What are top analysts saying about Johnson & Johnson? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Johnson & Johnson and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit